Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
anti-PEc monoclonal antibody
- Development stage
- Preclinical
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Administration
- Intravenous, Subcutaneous, Intramuscular, Inhalation, Topical, Oral, Intradermal, Intraperitoneal
01
Overview
Anti-PEc monoclonal antibody is an experimental **monoclonal antibody** developed to bind the Ec peptide of the **IGF-1Ec isoform** and thereby inhibit a prostate cancer-associated signaling element implicated in tumor proliferation, metastatic behavior, and tissue repair. Based on the provided publication, it appears to be a preclinical or early research-stage therapeutic antibody studied in **prostate cancer**, with the intended mechanism of neutralizing PEc-driven tumor biology rather than a marketed or formally code-named drug product. No clear sponsor company, proprietary development code, or commercial manufacturing information is identifiable from the provided source alone.
- Other names
- anti-PEc monoclonal antibodyanti-PEc MAb
02
Targets
IGF-1 (Insulin-like growth factor 1)
Beyond the preview
Go deeper on anti-PEc monoclonal antibody.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on anti-PEc monoclonal antibody.